CTH Antibodies

Santa Cruz Biotechnology features a diverse variety of CTH Antibodies for investigating cystathionine gamma-lyase (CTH) function and regulation. CTH Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cystathionine gamma-lyase plays a crucial role in the transsulfuration pathway, facilitating the conversion of cystathionine to cysteine, which is essential for the synthesis of glutathione and other critical biomolecules. The regulation of CTH is significant in various physiological processes, including cellular redox balance and the response to oxidative stress. Dysregulation of CTH has been implicated in several diseases, making it a vital target for therapeutic research. CTH research has revealed important insights into cellular metabolism and redox homeostasis. Understanding CTH function has significant implications for developing new therapeutic strategies in various pathological conditions. Recent studies have highlighted the importance of CTH in cardiovascular health and neurodegenerative disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of CTH's role in health and disease.